India · Legal status and models

Editorial composite showing legal books, a globe, a surrogacy agreement and related legal objects.

India: the legal framework for surrogacy

How India regulates surrogacy, what is prohibited, who may qualify, the certificate process, donor-gamete rules and the limits of cross-border recognition.

The short answer

As of 24 October 2026, India does not operate an open commercial surrogacy market. The Surrogacy (Regulation) Act, 2021, in force from 25 January 2022, permits only altruistic surrogacy within a tightly controlled statutory route and prohibits commercial surrogacy. “Altruistic” does not mean that any privately arranged pregnancy is automatically lawful: the intended parent or parents, surrogate mother, medical indication, clinic, certificates, consent, insurance and procedure must all meet the Act and Rules.

The practical answer is therefore conditional. A programme cannot be approved merely because a clinic advertises it, because a surrogate is willing, or because the parties sign a contract. The statute limits who may apply and requires official eligibility and essentiality documentation before the procedure. A payment labelled an “agency fee”, “gift”, “reward” or “compensation” may still fall within a prohibited commercial arrangement if its substance is remuneration or an incentive for the surrogacy service.

This page explains the national framework and the most consequential qualifications. It is not a case-specific legal opinion. State and Union Territory administration, current forms, individual medical evidence and later court orders can affect the route in a particular case.

Which law controls?

The controlling national statute is the Surrogacy (Regulation) Act, 2021 (Act 47 of 2021), effective from 25 January 2022. The Surrogacy (Regulation) Rules, 2022 supply forms and operational detail. Amendments to the Rules, especially the 2023 and 2024 changes to Form 2 on gametes, must be read with the parent Act and relevant court orders rather than in isolation.

The Act distinguishes altruistic surrogacy from commercial surrogacy. Altruistic surrogacy excludes charges, fees, remuneration and monetary incentives, but allows the medical expenses, prescribed expenses and insurance coverage specified by law. Commercial surrogacy includes commercialising the service or its components and payments or benefits in cash or kind to the surrogate mother, her dependants or representative, beyond the permitted categories. The Act also regulates clinics, advertising, the use of brokers, gamete and embryo trading, sex selection, consent and the treatment of a child born through surrogacy.

The Act is not the only relevant law. Assisted reproductive technology rules, the Medical Termination of Pregnancy Act, ordinary civil and family procedure, citizenship and immigration law may also matter. A conclusion about eligibility under the Surrogacy Act is not, by itself, a conclusion about nationality, a passport, foreign parentage recognition or permission to leave India.

The legal model in practice

The matrix below is a practical summary, not a substitute for checking every statutory condition. The legal label attached to a programme is not decisive; the actual payments, participants, medical basis and certificates matter.

Altruistic surrogacy: potentially lawful only when the statutory eligibility, medical, certification, clinic, consent, insurance and procedural conditions are met. The surrogate mother may not provide her own gametes under the Act.

Commercial surrogacy: prohibited. Section 3 bars clinics and professionals from conducting or associating with commercial surrogacy. Section 38 prohibits commercial arrangements and related conduct, including certain advertising, exploitation, brokerage or organised recruitment, embryo or gamete trading and sex selection. Calling money a gift does not resolve the issue if its substance is prohibited remuneration.

Payments: the statutory exception is narrow. Medical expenses, other expenses prescribed by the Rules and the required insurance are permitted categories; a profit, reward, fee or incentive for carrying the pregnancy is not transformed into an allowed expense by a private contract.

Foreign or cross-border programmes: India’s statutory definitions and certification system do not create a general route for foreign intended parents. Even if an Indian legal route is available, the destination or home country may apply separate parentage, nationality, passport and immigration rules.

IssueIndian rulePractical effect
Legal modelOnly altruistic surrogacy may proceed, and only if all statutory conditions are met.A private arrangement or clinic advertisement is not proof of legality.
MoneyMedical expenses, prescribed expenses and required insurance are the narrow permitted categories.Fees, rewards, incentives or disguised payments may trigger the commercial-surrogacy ban.
EligibilityThe intended parent(s), surrogate mother, medical indication and certificates must satisfy the Act and Rules.Check the applicant’s precise category and obtain official certificates before treatment.
Cross-borderIndian parentage rules and another country’s recognition, nationality and travel rules are separate questions.Plan for both jurisdictions; one approval does not guarantee the other.

Who may qualify?

The Act’s ordinary route is limited by statutory definitions and eligibility certificates. An “intending couple” is a legally married Indian man and woman who have a medical indication necessitating gestational surrogacy. The eligibility certificate requires the wife to be aged 23–50 and the husband 26–55 on the certification date. The couple must not have a surviving child, whether biological, adopted or born through surrogacy, subject to the statutory exception for an existing child who is mentally or physically challenged or has a life-threatening disorder or fatal illness with no permanent cure, as specified by the applicable rules; the required medical evidence and approval must be confirmed.

The Act separately defines an “intending woman” as an Indian woman who is a widow or divorcee aged 35–45. The ordinary statutory category does not simply extend to every single adult. The Rules specify that a single woman in this category must use her own eggs and donor sperm. The exact interaction of nationality, Indian origin, residence, OCI/NRI status and administrative practice should be checked for the individual applicant; do not infer eligibility from a clinic’s marketing.

The surrogate mother must be a willing, ever-married woman who has a child of her own and is aged 25–35 on the day of embryo implantation. She must receive medical and psychological fitness certification, cannot provide her own gametes for the surrogacy, and cannot act as a surrogate more than once in her lifetime. These are statutory conditions, not optional clinic preferences.

Certificates and the lawful process

The process is certificate-driven and should be checked with the appropriate authority in the relevant State or Union Territory before medical steps or financial commitments. First, the medical indication must fall within the Rules and be supported by the District Medical Board. The appropriate authority issues the certificate of essentiality only after the statutory requirements are satisfied.

The certificate of essentiality includes a medical-indication certificate, an order concerning parentage and custody of the child to be born through surrogacy passed by a Magistrate of the first class or above on an application involving the intended parent(s) and surrogate mother, and the required insurance coverage for the surrogate mother for 36 months covering postpartum delivery complications. The intended couple separately needs an eligibility certificate; the surrogate mother also needs her own eligibility certificate. Section 4(ii) expressly requires a Board recommendation for a couple of Indian origin or an intending woman seeking surrogacy; confirm whether this applies to the applicant’s exact category and which Board is competent. This recommendation is separate from the eligibility and essentiality certificates.

The clinic must be registered under the Act, and its registration should be verified directly rather than accepted from a broker or a website screenshot. Keep copies of every application, medical report, authority decision, consent, insurance policy, agreement, receipt and clinic registration. The statutory sequence and current forms should be confirmed locally; this summary does not replace the official checklist for the place where the procedure would occur.

Payments, contracts and prohibited conduct

The agreement cannot legalise what the Act prohibits. The surrogate mother’s permitted financial protection is limited to medical expenses, other prescribed expenses and insurance coverage. Payment of a fee, reward, remuneration, benefit or monetary incentive to the surrogate mother, her dependants or representative beyond those categories may constitute commercial surrogacy. The same concern applies to payments routed through an intermediary or described as a gift if the real purpose is to pay for the surrogacy service.

The Act restricts clinics and professionals from offering, conducting, promoting or associating with commercial surrogacy. It also prohibits specified advertising and recruitment conduct, exploitation of the surrogate mother or child, selling or trading embryos or gametes for surrogacy, importing embryos or gametes for surrogacy, and sex selection. A contract, waiver, private consent letter or overseas agency arrangement cannot displace these statutory prohibitions.

A written agreement is still important for documenting lawful responsibilities and the process, but it is not a licence to bypass eligibility, certificates, consent, insurance or the altruistic-only rule. Before signing, have independent Indian counsel review the proposed payments, who receives them, the medical and insurance terms, the parties’ obligations, and what happens if treatment is delayed, stopped or unsuccessful. Do not make a payment until its legal category and recipient are documented.

Donor gametes: a changing and fact-sensitive issue

Donor gametes require particular care because the Rules changed and the Supreme Court addressed the issue in case-specific orders. The 2023 amendment to Form 2 stated that an intending couple must use both gametes from the couple and that donor gametes were not allowed; it separately required a single woman in the statutory category to use her own eggs and donor sperm. The 2024 amendment changed the position: donor gametes may be used for an intending couple where the District Medical Board certifies that a medical condition necessitates them, provided the child will have at least one gamete from the intending couple. The 2024 text retains the own-eggs/donor-sperm rule for an intending woman.

The Supreme Court’s order of 18 October 2023 stayed the 2023 Form 2 restriction only as to the petitioner in W.P. (C) No. 830/2023 and allowed her to proceed if she otherwise met the Act’s conditions. On 17 May 2024, the Court held that the petitioner in W.P. (C) No. 61/2024 was entitled to the benefit of that earlier order, again subject to all other conditions. Separately, the 23 February 2024 order permitted two named applicants to proceed under the 2024 amendment if they were otherwise eligible. These are case-specific orders; they do not create a universal exemption or automatically remove the District Medical Board requirement under the amended Form 2 for every applicant.

Before any donor-gamete decision, obtain a written opinion addressing the current consolidated Rules, the medical indication, the District Medical Board’s role, the exact gamete combination, and any binding later judgment or order applicable to the case.

Consent, parentage and protection of the child

The surrogate mother must give written informed consent in a language she understands after the known side effects and after-effects have been explained. Under the Act, she may withdraw consent before the embryo is implanted. The law also limits abortion during a surrogacy procedure: the surrogate mother’s written consent and authorisation by the appropriate authority are required, subject to the Medical Termination of Pregnancy Act and applicable conditions. No intended parent, clinic or relative should treat a private contract as authority to override these safeguards.

The intended couple or intending woman may not abandon or disown a child born through a surrogacy procedure for reasons such as a genetic or birth defect, later medical condition, the child’s sex or the birth of more than one child. Section 8 provides that a child born out of a surrogacy procedure is deemed to be the biological child of the intending couple or intending woman and receives the rights and privileges available to a natural child under Indian law.

That statutory parentage rule must be read within the Act’s lawful procedure. It does not automatically decide how another country will record parentage, issue nationality documents or permit entry or exit. The surrogate’s autonomy, medical care, insurance and privacy should be addressed in practice, not treated as secondary to the intended parents’ plans.

Offences and penalties

The Act provides criminal penalties; the precise provision depends on the conduct and the person involved. Section 38 addresses prohibited commercial surrogacy and related conduct. Contraventions of the listed prohibitions may attract imprisonment of up to 10 years and a fine of up to ₹10 lakh. Section 40 applies to an intending couple, intending woman or person who seeks assistance for non-altruistic or commercial surrogacy: the first offence may attract imprisonment up to 5 years and a fine up to ₹5 lakh; a subsequent offence may attract imprisonment up to 10 years and a fine up to ₹10 lakh. Other contraventions may engage sections 39 or 41, depending on the actor and the provision breached.

These are statutory maximums, not a prediction of the sentence in any particular case. Do not rely on this summary to classify a proposed payment, agency, advertisement, clinic activity or gamete arrangement. The offence provisions, evidence, procedural requirements and any relevant court order need case-specific review. A foreign location, private agreement or intermediary does not automatically remove Indian-law exposure if conduct falls within the Act.

Age-transition cases and cross-border limits

Age rules have a narrow transitional exception in case law. In its judgment of 9 October 2025, the Supreme Court held that the age bar in section 4(iii)(c)(I) could not retrospectively block certain couples who had (1) begun the surrogacy process before 25 January 2022, (2) created and frozen embryos after gamete extraction before that date, and (3) reached the stage immediately before transferring those embryos to a surrogate mother. The competent authority must still be satisfied that all three conditions and the applicable Rule 14 requirements are met. Embryo creation or freezing alone is not a general exemption. Other statutory conditions remain, and application of the holding depends on the evidence and later decisions. Available texts of two 2026 Kerala High Court decisions illustrate the fact-specific boundary: Aju Kuriakose v Union of India (W.P.(C) No. 28694/2026, 11 September 2026) applied the transition principle to an embryo cryopreserved in 2018; Roopa P. Joy v Union of India (W.A. No. 1318/2026, 1 September 2026) dismissed an appeal involving embryos cryopreserved on 30 August 2022, after the Act commenced. These are fact-specific High Court applications, not a general waiver; verify the official copies and current procedural status before relying on them.

For cross-border cases, separate at least four questions: (1) whether the intended parent(s) qualify under Indian law; (2) whether the procedure and payments comply with Indian law; (3) how parentage will be established and recorded in India; and (4) whether the other relevant country will recognise parentage and issue travel, citizenship or immigration documents. A lawful domestic procedure does not by itself guarantee recognition abroad. The indexed MEA guidance states that no visa is issued to foreign nationals seeking to visit India to commission surrogacy, that FRRO/FRO permission is not granted to OCI cardholders for that purpose, and that exit permission is not to be granted to children born through surrogacy for foreign nationals, including OCI cardholders. The guidance describes a narrow “pipeline” category for arrangements commissioned before the 3 November 2015 circular where gestation had already commenced before that date; a foreign couple’s visa to collect the child is considered case by case and subject to documentary and other conditions. It separately says exit permission for a child from an arrangement commissioned on or before the circular is decided case by case. These legacy provisions are not a route for new arrangements. This is an administrative and immigration restriction, distinct from statutory eligibility under the Surrogacy Act. An Indian citizen living abroad is not the same legal category as a foreign national or OCI cardholder; verify citizenship, OCI status, Board-recommendation requirements and any applicable legacy-case exception separately.

Practical checklist before taking any step

Before starting, obtain a written eligibility assessment from an Indian lawyer who regularly handles surrogacy regulation. Confirm the intended parent(s)’ nationality and statutory category; the medical indication; the current age and surviving-child conditions; and whether any transitional judgment could genuinely apply. For any foreign-national or OCI connection, verify the current MEA/MHA visa and FRRO/FRO position before travel or payment. Do not rely on a clinic’s advertisement or a general online list.

Next, confirm the competent Appropriate Authority and current forms; obtain the District Medical Board’s medical-indication report and any required Board recommendation; secure the essentiality and eligibility certificates; verify the clinic’s registration; and document the surrogate mother’s eligibility, informed consent, insurance for 36 months and the legally permitted expenses. If donor gametes are proposed, obtain a current written analysis of the 2024 Rule and applicable court orders before treatment. Do not agree to a fee, reward, intermediary commission or “gift” until counsel confirms its legal character.

Finally, prepare for parentage and the child’s documents in every relevant country before pregnancy. Ask separate questions about Indian parentage/custody paperwork, birth registration, citizenship, passport, immigration and exit permission. Retain complete records.

Legal sources and case texts

Official legal texts, selected court orders and two third-party transcriptions of later High Court decisions. The list is not exhaustive of every State/Union Territory circular or later decision; verify official court copies and current status before relying on the High Court transcriptions.

  1. The Surrogacy (Regulation) Act, 2021 — India Code, Government of India — Official statutory text; check the consolidated version before reliance.
  2. Ministry of Health and Family Welfare — amendment to the Surrogacy (Regulation) Rules, 2022 concerning donor gametes — Official ministry page on the donor-gamete amendment.
  3. Supreme Court of India — order dated 23 February 2024, donor-gamete amendment proceedings — Supreme Court order quoting the 2024 Form 2 amendment.
  4. Supreme Court of India — order dated 17 May 2024, W.P. (C) No. 61/2024 and connected matters — Supreme Court order in a specific donor-gamete case; not a universal exemption.
  5. Supreme Court of India — Vijaya Kumari S & Another v Union of India and connected cases, judgment dated 9 October 2025 (2025 INSC 1209)
  6. Ministry of External Affairs, Government of India — Surrogacy Matters (foreign nationals and OCI) — Official guidance stating that visas are not issued to foreign nationals seeking to commission surrogacy in India and OCI cardholders are not granted FRRO/FRO permission; certain pre-circular pipeline cases may be considered case by case.
  7. Supreme Court of India — order dated 18 October 2023, donor-gamete/Form 2 proceedings — Official order in proceedings concerning the 2023 Form 2 donor-gamete restriction; read with the 2024 amendment and later orders, not as a universal exemption.
  8. Kerala High Court — Aju Kuriakose v Union of India, judgment dated 11 September 2026 (W.P.(C) No. 28694/2026) — Third-party transcription of a Kerala High Court judgment dated 11 September 2026 applying the transition principle to an embryo reported as cryopreserved in 2018; verify the official copy and current status.
  9. Kerala High Court — Roopa P. Joy v Union of India, judgment dated 1 September 2026 (W.A. No. 1318/2026) — Third-party transcription of a Kerala High Court appellate judgment dated 1 September 2026 dismissing an appeal involving embryos cryopreserved on 30 August 2022, after the Act commenced; verify the official copy and current status.

Guides for India

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards